We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Skip to Main Content

Best of 2016

2016 has been an exciting year of for JCC. The 10th volume was published, the journal's Impact Factor continued to rise to 6.585, and there were more article downloads than ever before. 

Explore our free to access selection of key papers published in 2016 including the most cited, most downloaded and highest Altmetric scoring articles. 

Thank you to all of the authors and reviewers that have contributed to the journal's success.

Highly cited articles

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
Krisztina B. Gecse, Barbara D. Lovász, Klaudia Farkas, et al.

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease
Severine Vermeire, Marie Joossens, Kristin Verbeke, et al.

Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO
Vito Annese, Dana Duricova, Corinne Gower-Rousseau, et al.

Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations
J. Sieczkowska, D. Jarzębicka, A. Banaszkiewicz, et al.

Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
Alon D. Levin, Manon E. Wildenberg, and Gijs R. van den Brink

Most downloaded articles

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass, G. Van Assche, J.O. Lindsay, et al.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass, James O. Lindsay, Andreas Sturm, et al.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord, Vito Annese, Stephan R. Vavricka, et al.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese, Laurent Beaugerie, Laurence Egan, et al.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass, Rami Eliakim, Fernando Magro, et al.

Top Altmetric scoring

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
Amy L. Lightner, Laura E. Raffals, Kellie L. Mathis, et al.

Long-term Efficacy of Vedolizumab for Ulcerative Colitis
Edward V. Loftus, Jr, Jean-Frédéric Colombel, Brian G. Feagan, et al.

Long-term Efficacy of Vedolizumab for Crohn’s Disease 
Severine Vermeire, Edward V. Loftus, Jr, Jean-Frédéric Colombel, et al.

Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
Imke Atreya, Alexandra Diall, Radovan Dvorsky, et al.

Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa
Hester Eppinga, Christa J. Sperna Weiland, H. Bing Thio, et al.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Subscribe Now